Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01WZL
|
||||
Former ID |
DIB016992
|
||||
Drug Name |
AVE-8112
|
||||
Synonyms |
AVE8112
|
||||
Indication | Parkinson's disease [ICD9: 332; ICD10:G20] | Phase 1 | [524229] | ||
Company |
The michael j. fox foundation for parkinson's research; sanofi us
|
||||
Target and Pathway | |||||
Target(s) | Type IV phosphodiesterase | Target Info | Inhibitor | [544367] | |
CAMP-specific 3',5'-cyclic phosphodiesterase 4B | Target Info | Inhibitor | [544367] | ||
CAMP-specific 3',5'-cyclic phosphodiesterase 4A | Target Info | Inhibitor | [544367] | ||
NetPath Pathway | IL5 Signaling Pathway | ||||
IL2 Signaling Pathway | |||||
PathWhiz Pathway | Purine Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.